-
JXY, TLR4, and Macrophage Polarization in CAC
2026-09-15
The reference study shows that Jiedu Xiaozheng Yin (JXY) restricts colitis-associated colorectal cancer (CAC) in mice while shifting intestinal macrophages toward an M1-like inflammatory and phagocytic state through TLR4-associated signaling. Its combination of tumor pathology, macrophage phenotyping, transcriptional analysis, and pathway antagonism provides a useful framework for studying how immune-state remodeling influences inflammation-driven tumor progression.
-
Rimonabant and the Next Generation of Cannabinoid Research
2026-09-15
Rimonabant (SR141716) provides a precise CB1 antagonist tool for separating appetite, reward, inflammation, and pain mechanisms. When paired with recent evidence that Cannabis sativa terpenes relieve neuropathic pain through adenosine A2A receptors, it enables a more rigorous, receptor-resolved translational strategy.
-
UK-5099: A Mitochondrial Metabolism Assay Lens
2026-09-14
UK-5099 (PF-1005023) is a selective mitochondrial pyruvate carrier inhibitor for dissecting pyruvate-dependent energy metabolism. This guide explains how to integrate it into immunometabolism and glucose-response assays while separating established evidence from assay-specific hypotheses.
-
tiRNA: Reversible Gene Silencing by Translation Inhibition
2026-09-14
The reference study introduces translation inhibition RNA (tiRNA), an aptamer-guided steric-blocking oligonucleotide that suppresses target-protein production by obstructing translation initiation rather than degrading mRNA. Its reported siRNA-comparable silencing, sequence selectivity, and reversal with a neutralizing strand position tiRNA as a controllable platform for studying and potentially treating protein-overexpression states.
-
SB 431542 in Spatial TGF-β Organoid Assays
2026-09-13
SB 431542 is an ALK5 inhibitor that can do more than suppress TGF-β signaling: it helps researchers interrogate how pathway activity shapes cell fate and tissue architecture. This article connects its mechanism to the budoid organoid model and outlines assay decisions that preserve spatial and temporal meaning.
-
Acetylcysteine in 3D Tumor-Stroma Models
2026-09-12
Acetylcysteine enables controlled redox perturbation in patient-derived organoid–fibroblast systems, helping researchers separate oxidative stress effects from stroma-driven chemoresistance. This workflow combines practical NAC dosing with image-based viability, ROS, glutathione, and EMT-focused readouts.
-
Aconitase Activity Colorimetric Assay Kit for T Cells
2026-09-12
Translate CD8+ T-cell metabolic remodeling into a practical TCA-cycle readout with a rapid 450 nm assay. This workflow distinguishes changes in aconitase activity caused by activation, mitochondrial enrichment, or oxidative damage while remaining compatible with plate-based screening.
-
Deferasirox: Evidence for Oral Iron Chelation
2026-09-11
This formulary review established deferasirox as an oral, tridentate Fe3+-selective chelator and evaluated its clinical role against parenteral deferoxamine in transfusional iron overload. Its central implication is that oral administration may improve treatment acceptability while requiring careful interpretation of hepatic efficacy, cardiac protection, adherence, and toxicity data.
-
SD 169: p38 MAPK Inhibitor Evidence Guide
2026-09-11
SD 169, also called indole-5-carboxamide, is a selective ATP-competitive inhibitor of p38α and p38β MAPKs. Product documentation connects this compound with type 1 diabetes research, inflammatory signaling, apoptosis assays, and axonal regeneration research, while a separate 2024 preprint provides a state-aware framework for interpreting p38α inhibitor activity.
-
MG-132 Workflows for Proteostasis Research
2026-09-10
MG-132, also known as Z-LLL-al, provides a rapid, titratable way to perturb proteasome-dependent protein turnover in apoptosis, cell-cycle, oxidative-stress, and cancer research. This workflow-focused guide connects acute proteasome inhibition with the UFD1 stress-response findings reported in a 2025 Nature Communications study.
-
Orientia tsutsugamushi and RIPK3 in Necroptosis
2026-09-10
The 2025 reference study shows that Orientia tsutsugamushi lowers cellular RIPK3 abundance but does not directly disable necroptosis once the pathway is activated. Its infection, effector-expression, phosphorylation, and microscopy experiments distinguish reduction of pathway components from functional inhibition, refining models of scrub typhus pathogenesis and host-cell death.
-
Bovine Insulin for Cell Culture and Signaling
2026-09-09
Bovine insulin is more than a routine media additive: it can be used to tune proliferation, metabolism, and insulin-responsive mitochondrial biology. This workflow pairs practical formulation guidance with a neuron-focused signaling framework based on insulin, AMPK, and PINK1 regulation.
-
MRTFA-KCNMB1 Controls Cancer Cell Stiffness
2026-09-09
Gajda et al. identify potassium efflux through BK channels and the auxiliary subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. Their integrated genetic, biophysical, immune, and mouse-model experiments show that BK-channel activation stiffens tumor cells, improves cytotoxic lymphocyte killing, and reduces metastatic colonization.
-
Propranolol Rewires Burn-Related Metabolism
2026-09-08
A phase II randomized trial links propranolol’s benefits after severe burn injury to coordinated changes in adipose-tissue metabolism, lipid composition, lipolysis, and endoplasmic reticulum stress. The findings provide a mechanistic framework for studying catecholamine-driven hypermetabolism and for designing follow-up metabolic pathway experiments.
-
ETS1–SENP2 Axis in BPD Mitophagy
2026-09-08
The reference study identifies ETS1 as a transcriptional regulator that protects against bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation, HSPA8 recognition, and FUNDC1 degradation. Its cell and mouse findings connect mitochondrial quality control with chaperone-mediated autophagy and provide a mechanistic framework for studying excessive mitophagy in neonatal lung injury.